ACRV short interest
Acrivon Therapeutics Inc. Common Stock · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 1,616,727 |
|---|---|
| Change vs prior report | 414,108 (+34.4%) |
| Change over six months | -26.0% |
| Days to cover | 4.40 (sector: 3.78) |
| Average daily volume | 367,469 |
| Rank in Healthcare | #476 of 922 by days to cover |
ACRV short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 1,616,727 | +34.4% | 4.40 | 367,469 |
| 2026-09-15 | 1,202,619 | +5.6% | 4.94 | 243,602 |
| 2026-08-31 | 1,139,237 | -7.8% | 2.78 | 409,741 |
| 2026-08-14 | 1,235,893 | -8.8% | 4.05 | 305,473 |
| 2026-07-31 | 1,355,015 | -8.9% | 4.30 | 315,055 |
| 2026-07-15 | 1,487,445 | -47.6% | 2.34 | 636,379 |
| 2026-06-30 | 2,840,348 | +0.5% | 7.58 | 374,493 |
| 2026-06-15 | 2,827,334 | +0.9% | 8.16 | 346,461 |
| 2026-05-29 | 2,801,992 | +12.2% | 6.07 | 461,247 |
| 2026-05-15 | 2,496,168 | +1.3% | 4.43 | 563,211 |
| 2026-04-30 | 2,463,735 | +3.2% | 2.29 | 1,076,681 |
| 2026-04-15 | 2,388,157 | +9.2% | 4.16 | 573,503 |
| 2026-03-31 | 2,185,860 | -9.2% | 3.42 | 638,817 |
| 2026-03-13 | 2,407,914 | +12.8% | 2.84 | 848,502 |
| 2026-02-27 | 2,135,443 | -8.3% | 2.19 | 973,653 |
| 2026-02-13 | 2,327,887 | +15.0% | 3.21 | 726,050 |
| 2026-01-30 | 2,024,627 | -73.1% | 1.81 | 1,119,438 |
| 2026-01-15 | 7,521,144 | +41.2% | 1.30 | 5,799,928 |
| 2025-12-31 | 5,325,324 | +4.0% | 13.40 | 397,354 |
| 2025-12-15 | 5,121,709 | +17.6% | 10.37 | 493,692 |
| 2025-11-28 | 4,356,053 | +17.6% | 8.62 | 505,257 |
| 2025-11-14 | 3,702,932 | +114.7% | 1.79 | 2,071,401 |
| 2025-10-31 | 1,724,519 | +5.5% | 4.93 | 350,149 |
| 2025-10-15 | 1,635,281 | +42.0% | 3.58 | 456,361 |
| 2025-09-30 | 1,151,365 | -9.9% | 2.14 | 537,682 |
import finzdata as yf
yf.Ticker("ACRV").short_interest # every report since 2017
yf.Client().short_interest(["ACRV"], start="2018-01-01")Healthcare short interest · ACRV price history · Who owns ACRV · All short interest